The U.S. Department of Health and Human Services removed COVID-19 from the immunization schedule for healthy pregnant women ...

See what infectious disease doctors have to say as government officials appear poised to scale back COVID vaccines and the ...

The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine with age restrictions after a six-week delay.

Federal health agencies were alerted in February 2021 to “large reports of myocarditis” in young people who received the Pfizer vaccine, but waited until late June to adjust the ...

CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...

Almost immediately after former US president Joe Biden's office announced he had been diagnosed with an aggressive prostate ...

The change was announced by the Food and Drug Administration, which falls under Health and Human Services. While Secretary ...

An FDA committee on Thursday recommended that COVID-19 vaccines for the 2025-2026 respiratory virus season — which, for the ...

The U.S. Food and Drug Administration approved Novavax’s Covid-19 vaccine with age restrictions after a six-week delay. The brand name is Nuvaxovid. Photo courtesy Novavax May 18 (UPI ...

The U.S. FDA has approved Novavax's COVID-19 vaccine, Nuvaxovid, for older adults and those aged 12 to 64 at risk of severe illness. Despite missed deadlines and regulatory challenges, the approval is ...